These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 93349)

  • 21. Antibodies to the strain-specific and cross-reactive determinants of the haemagglutinin of influenza H3N2 virus. 3. Selection of antigenic variations in vitro and in vivo.
    Haaheim LR
    Acta Pathol Microbiol Scand B; 1980 Dec; 88(6):341-5. PubMed ID: 6164248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of H-2I region-restricted cytolytic activity by an Lyt-2+ influenza virus-specific T lymphocyte clone.
    Morrison LA; Braciale VL; Braciale TJ
    J Immunol; 1985 Dec; 135(6):3691-6. PubMed ID: 2415581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoclonal antibodies as a tool for rabies epidemiological studies.
    Rollin PE; Sureau P
    Dev Biol Stand; 1984; 57():193-7. PubMed ID: 6084611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Target antigens for antibodies and complement at the cell surface of RSV-transformed fibroblasts.
    Prat M; Tato F; Tarone G; Comoglio PM
    Immunology; 1980 Feb; 39(2):179-85. PubMed ID: 6155325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complement fixing antigens in rabies. VI. Correlation of complement fixing and neutralizing antibodies.
    Rai Chowdhuri AN; Bhardwaj M; Sivaraman CA
    J Commun Dis; 1980 Dec; 12(4):197-200. PubMed ID: 7320482
    [No Abstract]   [Full Text] [Related]  

  • 26. Antibody-mediated enhancement of rabies virus infection in a mouse macrophage cell line (P388D1).
    King AA; Sands JJ; Porterfield JS
    J Gen Virol; 1984 Jun; 65 ( Pt 6)():1091-3. PubMed ID: 6726187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of monoclonal antibodies directed against murine T lymphocyte cell surface antigens on lymphokine production by cloned T lymphocytes reactive with class I MHC or Mls alloantigens.
    Lancki DW; Prystowsky MB; Vogel SN; Beller DI; Dialynas DP; Fitch FW
    J Immunol; 1984 Oct; 133(4):2051-7. PubMed ID: 6236262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of human monoclonal antibodies to rabies.
    Dorfman N; Dietzschold B; Kajiyama W; Fu ZF; Koprowski H; Notkins AL
    Hybridoma; 1994 Oct; 13(5):397-402. PubMed ID: 7860096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic restriction and fine specificity of human T cell clones reactive with rabies virus.
    Celis E; Karr RW; Dietzschold B; Wunner WH; Koprowski H
    J Immunol; 1988 Oct; 141(8):2721-8. PubMed ID: 2459225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens.
    Ozato K; Mayer N; Sachs DH
    J Immunol; 1980 Feb; 124(2):533-40. PubMed ID: 7188699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody-forming cell assays of avian paramyxoviruses: immunization of chickens demonstrates two serotype groups.
    Russell PH
    J Gen Virol; 1989 Oct; 70 ( Pt 10)():2645-51. PubMed ID: 2794974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Engineering of a recombinant trivalent single-chain variable fragment antibody directed against rabies virus glycoprotein G with improved neutralizing potency.
    Turki I; Hammami A; Kharmachi H; Mousli M
    Mol Immunol; 2014 Feb; 57(2):66-73. PubMed ID: 24091293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of the hybridoma technique for antibody production to group-specific antigens of avian oncornaviruses.
    Sovová V; Cerná H; Dostálová V; Hlozánek I
    Folia Biol (Praha); 1980; 26(5):366-8. PubMed ID: 6160063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Production of monoclonal antibodies against a wild strain of rabies virus].
    Akacem O; Benmansour A; Coulon P; Brahimi M; Benhassine M
    Arch Inst Pasteur Alger; 1992; 58():283-90. PubMed ID: 1309144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonal antibodies which recognize the acidic configuration of the rabies glycoprotein at the surface of the virion can be neutralizing.
    Raux H; Coulon P; Lafay F; Flamand A
    Virology; 1995 Jul; 210(2):400-8. PubMed ID: 7542418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surface markers, antigens, and receptors on murine T and B cells: part 1.
    Ahmed A; Smith AH
    Crit Rev Immunol; 1982 Jun; 3(4):331-69. PubMed ID: 6180863
    [No Abstract]   [Full Text] [Related]  

  • 37. Conformation-dependent accessibility of the linear epitopes located on the rabies virus glycoprotein.
    Kontsekova E; Macikova I; Novak M; Dedek L; Vrzal V; Kontsek P
    Viral Immunol; 1992; 5(3):213-20. PubMed ID: 1418319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
    Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM
    J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Requirements for the establishment of high-titered human monoclonal antibodies against tetanus toxoid using the Epstein-Barr virus technique.
    Kozbor D; Roder JC
    J Immunol; 1981 Oct; 127(4):1275-80. PubMed ID: 6268704
    [No Abstract]   [Full Text] [Related]  

  • 40. T-cell and B-cell responses to viral antigens at the clonal level.
    Sherman LA; Vitiello A; Klinman NR
    Annu Rev Immunol; 1983; 1():63-86. PubMed ID: 6085789
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.